Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41.
Identification of broadly cross-reactive HIV-1-neutralizing antibodies (bnAbs) may assist vaccine immunogen design. Here we report a novel human monoclonal antibody (mAb), designated m43, which co-targets the gp120 and gp41 subunits of the HIV-1 envelope glycoprotein (Env). M43 bound to recombinant...
Guardado en:
Autores principales: | Mei-Yun Zhang, Tingting Yuan, Jingjing Li, Andrew Rosa Borges, Jennifer D Watkins, Javier Guenaga, Zheng Yang, Yanping Wang, Richard Wilson, Yuxing Li, Victoria R Polonis, Seth H Pincus, Ruth M Ruprecht, Dimiter S Dimitrov |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0a713389e84f46b3a4b358d4a37ce068 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions.
por: Victor Buzon, et al.
Publicado: (2010) -
Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity.
por: Jyoti Sutar, et al.
Publicado: (2021) -
Glycoform and net charge heterogeneity in gp120 immunogens used in HIV vaccine trials.
por: Bin Yu, et al.
Publicado: (2012) -
Atomic force microscopy fishing and mass spectrometry identification of gp120 on immobilized aptamers
por: Ivanov YD, et al.
Publicado: (2014) -
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
por: Meimei Shan, et al.
Publicado: (2007)